Dostarlimab
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
July, 2024
July 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jun
Dostarlimab
Jun 12, 2024, 15:34 |
Insight
Piotr Wysocki: Dostarlimab combined with chemotherapy in dMMR/MSI-H advanced endometrial cancer patietns
Piotr Wysocki recently posted on LinkedIn: "Part 1 of the RUBY trial (NCT03981796) evaluated the…
Jun 10, 2024, 04:49 |
Blog
Ibrahim Halil Sahin: I discussed the findings of neoadjuvant rectal cancer study of Dostarlimab with Alison Kanski
Ibrahim Halil Sahin Assistant Professor of Medicine Division of Hematology/Oncology at University of Pittsburgh School of…
May 1, 2024, 09:57 |
Drugs
Tanja Obradovic: Dostarlimab chemotherapy in primary advanced or recurrent endometrial cancer
Tanja Obradovic, Vice President, Oncology Scientific Affairs at ICON, shared on LinkedIn: "Further inroads of…
Apr 14, 2024, 11:39 |
Drugs
Nieves Martinez Lago: FDA approvals Tumor-Agnostic drugs
Nieves Martinez Lago, Medical Oncologist at University Hospital Complex of Ferrol, shared on X/Twitter: "FDA…
Oct 24, 2023, 13:45 |
Blog
Stephen V Liu: ESMO23 - Dr. Solange Peters presents the PERLA randomized phase II study
Quoting Stephen V Liu, Associate Professor of Medicine and the Director of Thoracic Oncology at Georgetown University,…
All:
5
Posts:
1 - 100
The largest philanthropic partnership in The V Foundation’s history - Dolphins Cancer Challenge
Glecirasib: A Promising Novel KRAS G12C Inhibitor in Clinical Development
How the Médecins Sans Frontières Journal Inspired a Lifetime of Humanitarian Service: Paul Spiegel
OncoDaily Party and Yvonne Award Photos - Part 1
Michael Douglas: The Untold Story of His Battle Against Cancer
Facebook
RSS Feed
Twitter
Linkedin
Youtube